People / Staff

Phil Goldberg

Phil Goldberg, the director of PPI's Center for Civil Justice, is a partner at Shook Hardy & Bacon LLP. As a public policy attorney, Goldberg has more than two decades of experience with liability-related public policies and public affairs. From 1993 through 2000, he worked for Democratic Members of Congress, including Rep. Steve Rothman (NJ), when Mr. Rothman served on the House Judiciary Committee. Since joining Shook in 2003, Goldberg has regularly testified before legislatures, filed amicus briefs in federal and state courts, spoken at judicial education programs, and authored legal scholarship on important liability-related matters.

Writings

Blog

By / 9.21.2017

Debate has erupted in the past week and a half over Allergan’s surprise move to transfer all of its intellectual property rights to its blockbuster drug Restasis to the Saint Regis Mohawk Indian Tribe.  Allergan’s CEO Brent Saunders said he sold Allergan’s intellectual property rights in Restatis to protect it from the “double jeopardy” of […]

Op-eds and Articles

The pharmaceutical company Allergan shocked the prescription drug market this month when it transferred its intellectual property rights to its blockbuster drug Restasis, a treatment for dry eyes that generated $1.5 billion in sales last year, to the Saint Regis Mohawk Indian Tribe in exchange for an exclusive licensing deal. This bold tactic was intended […]

Op-eds and Articles

By / 9.18.2017

Phil Goldberg and Kathryn Constance discuss the impact that a recent Supreme Court decision could have on sanctions over discovery and other litigation disputes. The U.S. Supreme Court, in the little-known case Goodyear v. Haeger this past term, set important limits on a judge’s inherent authority sanctions, which could have significant implications in discovery disputes. […]

Op-eds and Articles

By / 8.11.2017

In New York and around the country, we count on judges and juries to get things right, but there is no way they can do their jobs if they are blindfolded from the facts. In the past few years, judges have exposed a national trend of plaintiffs’ lawyers hiding critical facts when suing over asbestos […]

PPI In the News

By and / 3.22.2017

Phil Goldberg, director of the Progressive Policy Institute’s Center for Civil Justice and Don Gifford, a member of PPI’s Center for Civil Justice Advisory Board, were quoted in the Legal NewsLine about a recent Missouri Supreme Court ruling: “The ruling offers some clarity on jurisdiction rules in Missouri—as in, courts don’t have jurisdiction over out-of-state claims—but […]

Blog

By / 2.8.2017

Phil Goldberg, Director of the Progressive Policy Institute’s Center for Civil Justice, testified in the Missouri Legislature on Monday, January 30 to urge the House Special Committee on Litigation Reform to adopt a package of bills to address venue and joinder abuse in the state. The testimony, provided on behalf of the American Tort Reform […]

Op-eds and Articles

By / 8.26.2016

This summer, during one of the least productive sessions in recent history, a rare bipartisan achievement slipped through Congress under the political radar. Democrats and Republicans came together with environmentalists and chemical manufacturers to reform the Toxic Substances Control Act (TSCA). So, what was the secret to TSCA’s success? All of these groups were unified […]

Other

By / 7.28.2016

Kim Stone, President of the Civil Justice Association of California, wrote an important op-ed on the California employment litigation environment, highlighting two cases currently before the Supreme Court of California that could impact the potential for additional litigation abuse. Her article, “State Supreme Court Has a Chance to Rein in PAGA Abuse,” ran in the […]

Op-eds and Articles

By / 7.15.2016

President Obama often cites escalating college costs and student debt burdens as major obstacles to upward mobility for many young Americans. He is right, but the White House just proposed a new rule that, rather than make college more affordable, makes it too easy for students to get out of paying back their student loans. The problem is that it could stick American taxpayers with the […]

Op-eds and Articles

By / 3.8.2016

In November, the Food & Drug Administration approved for the first time a modified, fast-growing salmon for human consumption. More than five years ago, FDA accepted a risk assessment’s conclusion that the modified fish was safe to eat and posed no threat to the environment. The FDA re-opened the process for additional comment because critics […]